These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16397233)

  • 1. Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma.
    Ryschich E; Lizdenis P; Ittrich C; Benner A; Stahl S; Hamann A; Schmidt J; Knolle P; Arnold B; Hämmerling GJ; Ganss R
    Cancer Res; 2006 Jan; 66(1):198-211. PubMed ID: 16397233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
    Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
    Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
    Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Kitade M; Yamazaki M; Tsujinoue H; Masaki T; Fukui H
    J Hepatol; 2004 Jul; 41(1):97-103. PubMed ID: 15246214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
    Lasagna N; Fantappiè O; Solazzo M; Morbidelli L; Marchetti S; Cipriani G; Ziche M; Mazzanti R
    Cancer Res; 2006 Mar; 66(5):2673-82. PubMed ID: 16510587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes.
    Kunz P; Hoffend J; Altmann A; Dimitrakopoulou-Strauss A; Koczan D; Eisenhut M; Bonaterra GA; Dengler TJ; Mier W; Haberkorn U; Kinscherf R
    J Nucl Med; 2006 Sep; 47(9):1515-24. PubMed ID: 16954561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice.
    Vincent F; Bonnin P; Clemessy M; Contrerès JO; Lamandé N; Gasc JM; Vilar J; Hainaud P; Tobelem G; Corvol P; Dupuy E
    Cancer Res; 2009 Apr; 69(7):2853-60. PubMed ID: 19318581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
    Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-angiogenic profile of bovine urinary bladder tumors distinguishes urothelial carcinomas from hemangiosarcomas.
    Carvalho T; Elias AP; Nunes T; Peleteiro MC; Dias S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):344-58. PubMed ID: 18022698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological aspects of angiogenesis in experimental liver metastases.
    Paku S; Lapis K
    Am J Pathol; 1993 Sep; 143(3):926-36. PubMed ID: 7689793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
    Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
    Ogawa Y; Suzuki T; Oikawa A; Hosono K; Kubo H; Amano H; Ito Y; Kitasato H; Hayashi I; Kato T; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Biochem Biophys Res Commun; 2009 May; 382(4):720-5. PubMed ID: 19318087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
    Liu B; Pan S; Dong X; Qiao H; Jiang H; Krissansen GW; Sun X
    Cancer Sci; 2006 Jul; 97(7):675-81. PubMed ID: 16827809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.